Immune checkpoint inhibitors for the treatment of non-small cell lung cancer brain metastases

Lung cancer has the highest risk of brain metastasis (BM) among all solid carcinomas. The emergence of BM has a significant impact on the selection of oncologic treatment for patients. Immune checkpoint inhibitors (ICIs) are the most promising treatment option for patients without druggable mutation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yuxi, Xu, Yan, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325750/
https://www.ncbi.nlm.nih.gov/pubmed/37106555
http://dx.doi.org/10.1097/CM9.0000000000002163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325750/
https://www.ncbi.nlm.nih.gov/pubmed/37106555
http://dx.doi.org/10.1097/CM9.0000000000002163

Ejemplares similares